Maureen Deehan
Chief Executive Officer at Vivtex Corp.
Maureen Deehan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Vivtex Corp. | Chief Executive Officer | 2023-02-20 | - |
| Chief Operating Officer | 2022-11-30 | 2023-02-20 |
Career history of Maureen Deehan
Former positions of Maureen Deehan
| Companies | Position | Start | End |
|---|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | 2018-05-31 | - |
Training of Maureen Deehan
| University of Glasgow School of Medicine | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Statistics
International
| United Kingdom | 3 |
| Norway | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Stock Market
- Insiders
- Maureen Deehan
- Experience
